Cell-Free Enzymatic DNA Synthesis Foundry Model
Underwrite continuous microfluidic enzymatic DNA printers utilizing engineered Terminal Deoxynucleotidyl Transferase (TdT) synthesizing gene-length 10,000 bp constructs without toxic phosphoramidite reagents. Model synthetic biology CDMO contracts ($0.08/bp), and 20-yr IRR.
1. Capacity & Unit Economics
2. Financial Returns & Yield
10kb ENZYMATIC GENE PRINTINGAnnual Net EBITDA
$0 / yr
20-Yr Project IRR
0.0%
Gross Revenue
$0 / yr
Total CapEx
$0
Annual OpEx
$0 / yr